Reuters logo
4 months ago
BRIEF-Avita Medical says FDA approves more compassionate use cases & sites for ReCell
April 6, 2017 / 11:42 PM / 4 months ago

BRIEF-Avita Medical says FDA approves more compassionate use cases & sites for ReCell

April 7 (Reuters) - Avita Medical Ltd:

* Asx alert-FDA approves more compassionate use cases & sites for recell-AVH.AX

* U.S. FDA approved further increase in number of patients who can be treated in U.S. With recell regenerative medical device under Avita Medical

* Expects to submit its clinical and non-clinical data package in mid-2017, with an anticipated FDA approval in the second calendar quarter of 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below